Published May 8, 2026, 2:39 PM ET · Updated 6 months ago · 2 sources
Google’s Isomorphic Labs to Raise Over $2 Billion in New Funding
bloomberg
·
Original Report
INFERY

Isomorphic Labs, an AI drug discovery firm spun out of Google DeepMind, is nearing a deal to raise over $2 billion in new funding, led by Thrive Capital. Alphabet is also expected to participate. The company, formed in 2021, plans to use the capital to enhance its drug design engine and expand globally. Isomorphic Labs has previously partnered with major pharmaceutical companies like Johnson & Johnson and Eli Lilly.